Ciphergen Biosystems announced this week that it has established a scientific advisory board to help direct its product-development strategies.

There are five members in the advisory board:

Robert Bast, vice president for translational research and a professor at the University of Texas MD Anderson Center is best known for developing the Ovarian Cancer 125 monoclonal antibody that led to the production of the CA125 radioimmunoassay for the monitoring of epithelial ovarian cancer.